Cargando…
Treatment with bone maturation and average lifespan of HPP model mice by AAV8-mediated neonatal gene therapy via single muscle injection
Hypophosphatasia (HPP) is an inherited skeletal disease characterized by defective bone and tooth mineralization due to a deficiency in tissue-nonspecific alkaline phosphatase (TNALP). Patients with the severe infantile form of HPP may appear normal at birth, but their prognosis is very poor. To dev...
Autores principales: | Matsumoto, Tae, Miyake, Koichi, Miyake, Noriko, Iijima, Osamu, Adachi, Kumi, Narisawa, Sonoko, Millán, José Luis, Orimo, Hideo, Shimada, Takashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408425/ https://www.ncbi.nlm.nih.gov/pubmed/34514025 http://dx.doi.org/10.1016/j.omtm.2021.06.006 |
Ejemplares similares
-
Treatment of hypophosphatasia by muscle-directed expression of bone-targeted alkaline phosphatase via self-complementary AAV8 vector
por: Nakamura-Takahashi, Aki, et al.
Publicado: (2016) -
Prolonged Survival and Phenotypic Correction of Akp2(−/−) Hypophosphatasia Mice by Lentiviral Gene Therapy
por: Yamamoto, Seiko, et al.
Publicado: (2011) -
Gene Therapy Using Recombinant AAV Type 8 Vector Encoding TNAP‐D(10)
Improves the Skeletal Phenotypes in Murine Models of Osteomalacia
por: Amadeu de Oliveira, Flavia, et al.
Publicado: (2022) -
Tyrosine triple mutated AAV2-BDNF gene therapy in a rat model of transient IOP elevation
por: Igarashi, Tsutomu, et al.
Publicado: (2016) -
Treatment of adult metachromatic leukodystrophy model mice using intrathecal administration of type 9 AAV vector encoding arylsulfatase A
por: Miyake, Noriko, et al.
Publicado: (2021)